Nisa Investment Advisors, LLC Iveric Bio, Inc. Transaction History

Nisa Investment Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$26.24 - $39.63 $6,245 - $9,431	238 Added 5.66%	4,440 $174,000
Q1 2023 May 02, 2023	SELL	$18.67 - $24.56 $7,468 - $9,824	-400 Reduced 8.69%	4,202 $102,000
Q3 2022 Nov 07, 2022	BUY	$9.4 - $18.59 $770 - $1,524	82 Added 1.81%	4,602 $110,000
Q2 2022 Aug 03, 2022	BUY	$9.12 - $18.9 $11,764 - $24,380	1,290 Added 39.94%	4,520 $43,000
Q1 2022 Apr 29, 2022	BUY	$12.15 - $16.83 $10,570 - $14,642	870 Added 36.86%	3,230 $54,000
Q4 2021 Feb 03, 2022	BUY	$13.83 - $18.78 $32,638 - $44,320	2,360 New	2,360 $33,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.